Hi there, what is happening at the PTCMA?

No images? Click here

 
PTCMA Logo
 

February 2026

PTCMA Update

 
 
 

21 February is Healthy Lifestyle Awareness Day

Every year on February 21, we celebrate Healthy Lifestyle Awareness Day, a day dedicated to promoting the importance of making healthy choices. In a world filled with fast food and sedentary lifestyles, it’s crucial to understand how our daily habits impact our overall health and well-being.

More info
 

HCP Subscription

Effective 1 March 2026, we will implement a yearly subscription for our Virtual CPD Programmes, which have previously been offered at no cost to practicing clinicians.
This change allows us to continue delivering exceptional quality and expand the value we provide to you.
The subscription will be open to all practicing healthcare professionals, inviting nurses, pharmacists and other allied healthcare practitioners.
Information to subscribe will be shared the last week of February.

 

Upcoming Virtual CPD Programmes

February events are still open to all clinicians with a valid MP number.

20 February - 09h00

Topic: Unmet Need in the treatment of Breast Cancer
Presenter: Dr Heide Hart (Oncologist)
Education sponsorship provided by Novartis

Breast Cancer
 

VCPD recordings - now available on PTCMA Portal

Where possible the Virtual CPDs are recorded and uploaded to the PTCMA Portal.

Recent advances in the treatment of advanced/metastatic NPC by Dr Samuel Fourie

View now

Deep dive into the New SA Obesity Guidelines by Prof. Marisa Noeth

View now

Injectable PrEP - A New Era in HIV Prevention by Dr Philippa Macdonald

View now
 
 

PTCMA online courses

 

DMA110
Demystifying Market Access in the South African Healthcare Environment

Moderated by Mark Brand

Independent HTA Consultant; MBA; Electrical Engineering; HTA (USB)

Course information
Register now!
 

Learning outcomes:

  • Understand macro environment issues
  • Successfully navigate complex market access processes 
  • Engage and manage important stakeholders strategically 
  • Introduction to health technology assessment - HTA
  • Enhance your applications for reimbursement
  • Understanding value and develop a value proposition 
  • Align business and market access strategies
  • Integrate market access function into your portfolio

Date
9 Mar - 10 Apr 2026

Contact sessions
12, 19 & 26 Mar @19h00 via Zoom

DMA110 Cost (excl. VAT)

R 4 660 Corp Mem
R 4 950 Stan Mem
R 5 245 Ind Mem
R 5 830 Non-Mem

 
 

Certificate of completion awarded

 

IRT101
Intervention Research and Clinical Trials

Moderated by Prof Danie van Zyl

Head of the Department of Internal Medicine in the Faculty of Health Sciences at the University of Pretoria

Course information
Register now!
 

Intervention research is research undertaken to develop new or improved healthcare interventions and to evaluate the effectiveness of pharmacologic interventions. This is considered to be the most reliable evidence in healthcare research. In a clinical trial setting, the researcher aims to explore whether a medical strategy, a treatment or a device is safe and effective for humans. Clinical trials produce the best data available for healthcare decision making by utilising stringent scientific standards and protocols in the design and development of intervention research.

Dates

4 May - 5 Jun 2026

Contact session to be announced

 
 

15 CPD points awarded

 

HEC101
Health Economic and HTA Research

Moderated by Prof Edina Sinanovic

Professor & Head of Health Economics Division at the University of Cape Town

Course information
Register now!
 

Health economics, which is one of the important components of HTA, covers a wide spectrum of activities related to the cost-effectiveness, affordability and access to medicines. The tools used in health economics may differ depending on the perspective and setting.
This module takes a micro-level view of the health economics of a specific healthcare intervention rather than that of a healthcare programme.
However, it incorporates all the fundamental principles of health economics so that you will be able to use these in many different settings.

Dates

4 May - 5 Jun 2026

No contact sessions

 
 

15 CPD points awarded

 

EBD101
Evidence Based Decision Making in Healthcare

Moderated by:
Prof Manie de Klerk

Extraordinary Associate Professor: University of Stellenbosch Business School and Clinical Director at Advanced Health Intelligence

and Prof Edina Sinanovic
Professor & Head of Health Economics Division at the University of Cape Town

Course information
 

In this module we will aim to assist the phrasing of focused and specific clinical questions requiring decision making, search medical literature and apply validity criteria to therapeutic, health economic and meta-analytic research. By the end of this module, you should be able to understand critical appraisal, learn about evaluating Harm and where Guidelines fit in. You will review economic evaluations with a check list and work through some practical examples in Health Economics.

Register now!

Dates

4 May - 5 Jun 2026

No contact sessions

 
 

20 CPD points awarded

 

101 courses Cost (excl. VAT)

R 4 365 Corporate Members
R 4 640 Standard Members

R 4 910 Individual Members
R 5 455 Non-Members

 

PHARMACEUTICAL & TECHNOLOGY CLINICAL MANAGEMENT ASSOCIATION

 
FacebookLinkedIn
 
  Share 
  Tweet 
  Share 
  Forward 

PTCMA
Bryanston, Johannesburg

You are receiving this email because you have shown interest in the PTCMA online course, participated in one of the modules or you are on the PTCMA mailing list.
Please note that if you should unsubscribe, you will no longer receive any monthly events updates, notices of workshops or online courses. You will still receive the CPD invitations as those are sent from the PTCMA portal and can be managed by editing your profile or emailing Janine at janine@ptcma.org.za.
Unsubscribe